BECTON, DICKINSON AND COMPANY (BDX) Profit Breakdown
- 2026-06-30: Interventional $912.00M; Medical Essentials $849.00M; Connected Care $696.00M; BioPharma Systems $308.00M.
- 2025-06-30: Interventional $882.00M; Medical Essentials $825.00M; Connected Care $668.00M; BioPharma Systems $287.00M.
Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.
- Available history
- 2007-09-30 to 2026-06-30
- Data captured
Profit by product
Gross margin: each quarter (3 month)
| Quarter end | Interventional | Medical Essentials | Connected Care | BioPharma Systems |
|---|---|---|---|---|
| 2026-06-30 | $912.00M derived | $849.00M derived | $696.00M derived | $308.00M derived |
| 2025-06-30 | $882.00M derived | $825.00M derived | $668.00M derived | $287.00M derived |
Operating income: each quarter (3 month)
| Quarter end | Interventional | Medical Essentials | Connected Care | BioPharma Systems |
|---|---|---|---|---|
| 2026-06-30 | $565.00M | $617.00M | $395.00M | $259.00M |
| 2025-06-30 | $549.00M | $612.00M | $417.00M | $239.00M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |